PLUR Pluri Inc.: Rasio rega marang prakiraan pendapatan

Pluri Inc. is recognized as an authoritative developer of cell-based therapies for severe ischemic pathologies. The forward P/S dynamics for Pluri Inc. on the GURU.Markets chart demonstrate a pivot driven by the creation of 3D platforms for regenerative medicine and contracts with US government agencies regarding radiation protection. The current level of 11.50 sets the magnitude of the metric, determining the issuer's degree of market maturity.

Pluristem Therapeutics - Rasio kapitalisasi marang dodolan sing dikarepake PLUR (periode 28.04.2023 - 13.11.2026)

Ringkesan rincian data analitis pluri-biotech.com (PLUR)

- rega pasar lan target rega analis:

Bagan rega Pluri|PLUR - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Nilai pasar PLUR|PLUR - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Pluri|PLUR - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku pluri-biotech.com|PLUR - Gunggung Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- rincian asil keuangan lan kelipatan valuasi:

PLUR - Bathi pungkasan|Proyeksi bathi mangsa ngarep Pluri Inc.|PLUR - Periode bali modal bisnis|Prakiraan rega marang bathi Pluri|PLUR - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA PLUR|PLUR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Pluri|PLUR - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan pluri-biotech.com|PLUR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Pluri Inc.

- indikator volume dodolan lan pendapatan:

PLUR - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan Pluri|PLUR - Rasio rega marang dodolan|Rasio rega marang prakiraan pendapatan PLUR

Pambiji fundamental:PLUR (Pluri Inc)

High-tech cell therapy production in Israel with autonomous power supply forms the foundation for scaling revenue at Pluri Inc. This forward P/S indicator compares the current market value of the business with projected sales volume, allowing investors to assess the degree of asset overheating and determine a fair balance between the share price and the fundamental potential for revenue growth.

Karo sapa Pluri Inc. saingan